Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 25.06 is in line with its 1-year average of 23.46, around the middle of its 1-year range (12.67–38.00).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 25.06.
QUICK RATIO (ACID-TEST)
25.06
QUICK RATIO (ACID-TEST) AVG TTM
N/A
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+647.96%
vs the sector median at left
SpyGlass Pharma, Inc. Common Stock
Market Cap
$828.48M
Quick Ratio (Acid-Test)
25.06
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$833.81M
Quick Ratio (Acid-Test)
9.52
TTM Avg
4.26
3Y Avg
6.09
5Y Avg
7.80
Market Cap
$838.16M
Quick Ratio (Acid-Test)
7.96
TTM Avg
6.81
3Y Avg
6.62
5Y Avg
6.62
Market Cap
$838.62M
Quick Ratio (Acid-Test)
4.03
TTM Avg
6.29
3Y Avg
5.71
5Y Avg
7.79
Market Cap
$816.13M
Quick Ratio (Acid-Test)
14.93
TTM Avg
20.63
3Y Avg
16.30
5Y Avg
22.70
Market Cap
$852.35M
Quick Ratio (Acid-Test)
3.05
TTM Avg
34.00
3Y Avg
26.34
5Y Avg
26.34
Market Cap
$853.13M
Quick Ratio (Acid-Test)
1.79
TTM Avg
2.17
3Y Avg
1.93
5Y Avg
2.04
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. Common Stock (SGP) | $828.48M | 25.06 | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $833.81M | 9.52 | 4.26 | 6.09 | 7.80 |
| Beta Bionics, Inc. (BBNX)vs › | $838.16M | 7.96 | 6.81 | 6.62 | 6.62 |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | 4.03 | 6.29 | 5.71 | 7.79 |
| Ardelyx, Inc. (ARDX)vs › | $817.67M | 3.15 | 4.21 | 3.84 | 4.13 |
| Jade Biosciences, Inc. (JBIO)vs › | $816.13M | 14.93 | 20.63 | 16.30 | 22.70 |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | 3.05 | 34.00 | 26.34 | 26.34 |
| InMode Ltd. (INMD)vs › | $804.16M | 7.28 | 9.00 | 9.42 | 9.03 |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 1.79 | 2.17 | 1.93 | 2.04 |
| Alumis Inc. (ALMS)vs › | $855.38M | 6.74 | 5.17 | 5.15 | 5.15 |
Quick Ratio
25.06
Excludes inventory
Current Ratio
25.06
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 25.06 |
| 2026-03-31 | 38.00 |
| 2025-12-31 | 12.67 |
| 2025-09-30 | 18.11 |
